EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Significant Impact of Previous Major Cardiovascular Events (MACEs) and Viremia on Risk of New MACEs in People Living with HIV on Antiretroviral Therapy

Caterina Candela iD, Alessia Siribelli iD, Tommaso Clemente iD, Riccardo Lolatto iD, Michele Bellomo, Vincenzo Stabile, Hamid Hasson, Vincenzo Spagnuolo, Antonella Castagna, Silvia Nozza iD, Camilla Muccini iD

Medicines · 29.01.2026 · 13 (1) · 4

DOI: 10.3390/medicines13010004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medicines, online erschienen am 29.01.2026. Verfasst von Caterina Candela und 10 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Unit, IRCCS San Raffaele Scientific Institute, Via Stamira D'Ancona 20, 20127 Milan, Italy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Major cardiovascular events (MACEs) in people with HIV (PWH) may be partly related to antiretroviral therapy (ART) and persistent inflammation. The aim of the study was to evaluate the association between targeted variables and MACEs.

Methods

Retrospective, single-center study conducted on PWH receiving ART between January 2010 and April 2024, classified according to HIV-RNA levels: virological suppression ( 1000 copies/mL in 844 (25.2%). Overall, 300 MACEs occurred, including 53 (17.7%) repeated events, with total incident rate of 0.00976 events per person-year. The risk of MACEs was significantly associated with previous MACEs (Hazard Ratio, HR 3.385, p-value < 0.001) and viremia > 1000 copies/mL at baseline (HR 2.209, p-value 0.039). Their onset was also significantly associated with greater age at baseline and years on ART, hypertension, diabetes, lower HDL, and higher triglycerides.

Conclusions

PWH on ART with HIV-RNA > 1000 copies/mL at baseline and a previous MACE presented higher risk of developing MACEs.

Schlagwörter

Stichwörter der Autor:innen

ARTMACEsPWHlow-level viremiavirological suppression

Autor:innen und Institutionen

  • Infectious Diseases Unit, IRCCS San Raffaele Scientific Institute, Via Stamira D'Ancona 20, 20127 Milan, Italy.
  • Infectious Diseases Unit, Vita-Salute San Raffaele University, Via Olgettina 58, 20132 Milan, Italy.

ORCID-Profile: Caterina Candela, Alessia Siribelli, Tommaso Clemente, Riccardo Lolatto, Silvia Nozza, Camilla Muccini

Zitieren

APA

Candela, C., Siribelli, A., Clemente, T., Lolatto, R., Bellomo, M., Stabile, V., Hasson, H., Spagnuolo, V., Castagna, A., Nozza, S., & Muccini, C. (2026). Significant Impact of Previous Major Cardiovascular Events (MACEs) and Viremia on Risk of New MACEs in People Living with HIV on Antiretroviral Therapy. Medicines, 13(1), 4. https://doi.org/10.3390/medicines13010004

Vancouver

Candela C, Siribelli A, Clemente T, Lolatto R, Bellomo M, Stabile V, et al. Significant Impact of Previous Major Cardiovascular Events (MACEs) and Viremia on Risk of New MACEs in People Living with HIV on Antiretroviral Therapy. Medicines. 2026;13(1):4. doi:10.3390/medicines13010004

BibTeX
@article{Candela2026,
  author = {Candela, Caterina and Siribelli, Alessia and Clemente, Tommaso and Lolatto, Riccardo and Bellomo, Michele and Stabile, Vincenzo and Hasson, Hamid and Spagnuolo, Vincenzo and Castagna, Antonella and Nozza, Silvia and Muccini, Camilla},
  title = {Significant Impact of Previous Major Cardiovascular Events (MACEs) and Viremia on Risk of New MACEs in People Living with HIV on Antiretroviral Therapy},
  journal = {Medicines},
  year = {2026},
  volume = {13},
  number = {1},
  pages = {4},
  doi = {10.3390/medicines13010004}
}
Kostenlos starten →